Takuji Okusaka
International University of Health and Welfare
623 Papers
3K Citations
Takuji Okusaka is an academic researcher from International University of Health and Welfare. The author has contributed to research in topics: Medicine & Gemcitabine. The author has an hindex of 67, co-authored 490 publications. Previous affiliations of Takuji Okusaka include National Cancer Research Institute & Kyorin University.
Chat about Author
Papers
Medical oncologists attitude toward end-of-life discussions: Effects of their experience, perceptions, and beliefs.
TL;DR: A nationwide survey of medical oncologists on EOLd timing regarding prognosis, hospice, preferred site of death, and do-not-resuscitate (DNR) status with advanced cancer patients found that perceptions of good death, beliefs contributing to E OLd timing, and determinants of early discussions were clarified.
1
Phase I study of ontuxizumab, a humanized monoclonal antibody (mAb) recognizing endosialin in Japanese patients (pts) with hepatocellular carcinoma (HCC).
TL;DR: Endosialin is a cell surface glycoprotein that is expressed on cells involved in the development of tumor vasculature, primarily pericyte and stromal fibroblast and Ontuxizumab is a drug for the treatment of central giant cell granuloma.
1
Chemotherapie bei älteren Patientinnen mit gynäkologischen Krebserkrankungen
Thomas Ostermann,Shuichi Mitsunaga,Koichi Goto,Miyuki Hara,Hiroyuki Okuyama,Hideaki Takahashi,Hans Helge Bartsch,Johannes Bruns,Takuji Okusaka,Motohiro Kojima,Izumi Ohno,Hans Tesch,Christian Ihling,Frauke Musial,Arndt Büssing,Peter Heusser,Kyung-Eun Choi,Yusuke Nakayama,Masafumi Ikeda,Satoshi Shimizu,Hartmut Link,Stephan Schmitz +21 more
- 01 Jan 2014
TL;DR: In this article, a study about Vertraglichkeit, Sicherheit und Durchfuhrbarkeit einer Chemotherapie bei alten Patientinnen mit gynakologischen Krebserkrankun is presented.
1
•Journal Article
A case of pancreatic cancer achieving symptomatic improvement with systemic chemotherapy.
H. Kosakamoto,Shuichi Okada,Hideki Ueno,Takuji Okusaka,Masafumi Ikeda,Noriaki Tanaka,Masayoshi Yoshimori,Matsuno Y +7 more
TL;DR: It is important to achieve symptomatic improvement in patients with pancreatic cancer, and serum interleukin-6 levels may be useful to evaluate a symptomatic response to chemotherapy.
1
Impact of Renal Function on S-1 + Radiotherapy for Locally Advanced Pancreatic Cancer: An Integrated Analysis of Data From 2 Clinical Trials.
Satoshi Kobayashi,Makoto Ueno,Gakuto Ogawa,Akira Fukutomi,Masafumi Ikeda,Takuji Okusaka,Tosiya Sato,Yoshinori Ito,Tomohiro Kadota,Tatsuya Ioka,Kazuya Sugimori,Naohiro Sata,Shoji Nakamori,Kyoko Shimizu,Nobumasa Mizuno,Hiroshi Ishii,Junji Furuse +16 more
TL;DR: In this article, the effect of renal function on the safety of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer (LAPC) was evaluated, where patients were divided into high creatinine clearance (CCr; ≥80 mL/min) and low CCr (<80 mL /min) groups.
1